share_log

Cambridge Investment Research Advisors Inc. Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cambridge Investment Research Advisors Inc. Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

剑桥投资研究顾问公司增持直觉外科公司股份有限公司(纳斯达克代码:ISRG)
Defense World ·  2022/09/24 05:01

Cambridge Investment Research Advisors Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 4.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 37,663 shares of the medical equipment provider's stock after buying an additional 1,619 shares during the period. Cambridge Investment Research Advisors Inc.'s holdings in Intuitive Surgical were worth $7,559,000 as of its most recent SEC filing.

根据剑桥投资研究顾问公司提交给美国证券交易委员会(美国证券交易委员会)的最新文件,该公司在第二季度增持了直觉外科公司股份(评级代码:ISRG-GET)4.5%。该公司持有这家医疗设备提供商37,663股股票,在此期间又购买了1,619股。截至最近提交的美国证券交易委员会申报文件,剑桥投资研究顾问公司持有的直觉外科公司股份价值7,559,000美元。

Several other institutional investors also recently added to or reduced their stakes in ISRG. Standard Family Office LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $27,000. IronBridge Private Wealth LLC increased its position in Intuitive Surgical by 200.0% during the 4th quarter. IronBridge Private Wealth LLC now owns 81 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 54 shares during the period. Comprehensive Financial Consultants Institutional Inc. purchased a new position in Intuitive Surgical during the 4th quarter valued at about $30,000. JFS Wealth Advisors LLC increased its position in Intuitive Surgical by 145.2% during the 1st quarter. JFS Wealth Advisors LLC now owns 103 shares of the medical equipment provider's stock valued at $31,000 after purchasing an additional 61 shares during the period. Finally, Vectors Research Management LLC increased its position in Intuitive Surgical by 200.0% during the 4th quarter. Vectors Research Management LLC now owns 90 shares of the medical equipment provider's stock valued at $32,000 after purchasing an additional 60 shares during the period. Hedge funds and other institutional investors own 82.44% of the company's stock.

其他几家机构投资者最近也增持或减持了ISRG的股份。标准家族办公室有限责任公司在第四季度购买了直觉外科公司的一个新头寸,价值约27,000美元。铁桥私人财富有限责任公司第四季度增持直觉外科公司股份200.0%。Ironbridge Private Wealth LLC在此期间又购买了54股,现在拥有81股这家医疗设备提供商的股票,价值2.9万美元。综合财务咨询机构有限公司在第四季度购买了直觉外科公司的新头寸,价值约30,000美元。第一季度,JFS Wealth Advisors LLC将直觉外科公司的持仓增加了145.2%。JFS Wealth Advisors LLC在此期间又购买了61股,现在拥有103股这家医疗设备提供商的股票,价值3.1万美元。最后,Vectors Research Management LLC在第四季度将其在直觉外科公司的头寸增加了200.0%。在此期间购买了另外60股后,向量研究管理有限责任公司现在拥有这家医疗设备提供商90股股票,价值3.2万美元。对冲基金和其他机构投资者持有该公司82.44%的股票。

Get
到达
Intuitive Surgical
直觉外科公司
alerts:
警报:

Analyst Upgrades and Downgrades

分析师升级和下调评级

ISRG has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Intuitive Surgical from $225.00 to $205.00 in a report on Friday, July 22nd. BTIG Research lowered their target price on shares of Intuitive Surgical from $355.00 to $247.00 and set a "buy" rating for the company in a research note on Monday, July 18th. Piper Sandler lifted their target price on shares of Intuitive Surgical from $255.00 to $260.00 and gave the stock an "overweight" rating in a research note on Thursday, August 18th. The Goldman Sachs Group decreased their price objective on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating for the company in a research note on Friday, July 29th. Finally, Morgan Stanley decreased their price objective on shares of Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating for the company in a research note on Friday, July 15th. Six research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $268.00.

ISRG一直是最近一些分析师报告的主题。在7月22日星期五的一份报告中,德意志银行将直觉外科公司股票的目标价从225.00美元下调至205.00美元。BTIG Research将直觉外科公司股票的目标价从355.00美元下调至247.00美元,并在7月18日周一的一份研究报告中为该公司设定了“买入”评级。派珀·桑德勒将直觉外科公司股票的目标价从255.00美元上调至260.00美元,并在8月18日周四的一份研究报告中给予该股“增持”评级。高盛夫妇将直觉外科公司的股票目标价从319.00美元下调至273.00美元,并在7月29日星期五的一份研究报告中为该公司设定了“买入”评级。最后,摩根士丹利将直觉外科公司股票的目标价从300.00美元下调至225.00美元,并在7月15日(星期五)的一份研究报告中为该公司设定了“同等权重”评级。6名研究分析师对该股的评级为持有,12名分析师对该公司的评级为买入。根据MarketBeat的数据,直觉外科公司目前的平均评级为“适度买入”,共识目标价为268.00美元。

Intuitive Surgical Trading Down 0.3 %

直觉外科公司股价下跌0.3%

ISRG stock opened at $190.52 on Friday. The business has a 50 day simple moving average of $218.90 and a 200-day simple moving average of $233.18. Intuitive Surgical, Inc. has a twelve month low of $186.83 and a twelve month high of $369.69. The company has a market capitalization of $68.04 billion, a P/E ratio of 48.48, a PEG ratio of 5.43 and a beta of 1.31.
ISRG股票周五开盘报190.52美元。该业务的50日简单移动均线切入位在218.90美元,200日简单移动均线切入位在233.18美元。直觉外科公司的股价跌至186.83美元的12个月低点和369.69美元的12个月高点。该公司市值为680.4亿美元,市盈率为48.48倍,聚乙二醇率为5.43倍,贝塔系数为1.31。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last issued its quarterly earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share for the quarter, missing the consensus estimate of $1.04 by ($0.19). Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the business earned $1.42 earnings per share. Research analysts predict that Intuitive Surgical, Inc. will post 3.76 EPS for the current fiscal year.

直觉外科公司(纳斯达克代码:ISRG-GET Rating)上一次发布季度收益报告是在7月21日星期四。这家医疗设备提供商公布本季度每股收益为0.85美元,低于普遍预期的1.04美元(0.19美元)。直觉外科公司的股本回报率为12.04%,净利润率为24.05%。该公司本季度营收为15.2亿美元,而分析师预期为15.6亿美元。去年同期,该业务每股收益为1.42美元。研究分析师预测,直觉外科公司公司本财年每股收益将达到3.76欧元。

Insider Buying and Selling

内幕买卖

In related news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now directly owns 11,224 shares of the company's stock, valued at $2,671,760.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now directly owns 11,224 shares of the company's stock, valued at $2,671,760.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 9,000 shares of the stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the transaction, the executive vice president now owns 217 shares of the company's stock, valued at approximately $48,825. The disclosure for this sale can be found here. Insiders sold a total of 101,162 shares of company stock valued at $22,062,916 over the last three months. 0.90% of the stock is currently owned by company insiders.

在相关新闻中,董事在8月3日星期三的一次交易中出售了6,375股该公司股票。股票以238.04美元的平均价格出售,总成交金额为1,517,505.00美元。出售完成后,董事现在直接拥有11,224股该公司股票,价值2,671,760.96美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过美国证券交易委员会网站。在相关新闻中,董事在8月3日星期三的一次交易中出售了6,375股该公司股票。股票以238.04美元的平均价格出售,总成交金额为1,517,505.00美元。出售完成后,董事现在直接拥有11,224股该公司股票,价值2,671,760.96美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过美国证券交易委员会网站。此外,执行副总裁米里亚姆·库雷特在7月27日星期三的一次交易中出售了9000股该股。这只股票的平均售价为225.00美元,总价值为2,025,000.00美元。交易完成后,执行副总裁总裁现在持有该公司217股股票,价值约48,825美元。关于这次销售的披露可以找到这里。过去三个月,内部人士总共出售了101,162股公司股票,价值22,062,916美元。公司内部人士目前持有该公司0.90%的股份。

About Intuitive Surgical

关于直觉外科公司

(Get Rating)

(获取评级)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

直觉外科公司公司开发、制造和营销产品,使医生和医疗保健提供者能够在美国和国际上提高微创护理的质量和获得微创护理的机会。该公司提供达芬奇外科系统,以实现使用微创方法进行复杂手术;以及离子腔内系统,将其商业产品从外科扩展到能够进行微创肺活组织检查的诊断程序。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 2 Semiconductor Stocks To Watch For Reversals
  • 免费获取斯托克新闻网关于直觉外科公司的研究报告
  • MarketBeat:回顾一周9/19-9/23
  • 为什么特斯拉的股票保持弹性?
  • 好市多盈利后价格疲软是买入的好时机吗?
  • 小盘股的裁员是楼市的晴雨表吗?
  • 需要关注的2只半导体类股走势逆转

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直觉外科公司日报》的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯接收对直觉外科公司及相关公司的最新新闻和分析师评级的每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发